Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

In the version of this article originally published, there was an error in Fig. 2n. The top line of the HR comparison chart originally was Atezo + bev vs sun. It should have been Atezo + bev vs atezo. The error has been corrected in the HTML and PDF versions of this article.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature medicine 2018-12, Vol.24 (12), p.1941-1941
Hauptverfasser:	McDermott, David F., Huseni, Mahrukh A., Atkins, Michael B., Motzer, Robert J., Rini, Brian I., Escudier, Bernard, Fong, Lawrence, Joseph, Richard W., Pal, Sumanta K., Reeves, James A., Sznol, Mario, Hainsworth, John, Rathmell, W. Kimryn, Stadler, Walter M., Hutson, Thomas, Gore, Martin E., Ravaud, Alain, Bracarda, Sergio, Suárez, Cristina, Danielli, Riccardo, Gruenwald, Viktor, Choueiri, Toni K., Nickles, Dorothee, Jhunjhunwala, Suchit, Piault-Louis, Elisabeth, Thobhani, Alpa, Qiu, Jiaheng, Chen, Daniel S., Hegde, Priti S., Schiff, Christina, Fine, Gregg D., Powles, Thomas
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/1059/2325 631/67/1857 631/67/589/1588/1351 692/308/2779/777 Bevacizumab Biomedical and Life Sciences Biomedicine Cancer Research Infectious Diseases Metabolic Diseases Molecular Medicine Neurosciences Publisher Correction Renal cell carcinoma
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In the version of this article originally published, there was an error in Fig. 2n. The top line of the HR comparison chart originally was Atezo + bev vs sun. It should have been Atezo + bev vs atezo. The error has been corrected in the HTML and PDF versions of this article.
ISSN:	1078-8956 1546-170X
DOI:	10.1038/s41591-018-0235-z